Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The alpha-synuclein mutation E46K promotes aggregation in cultured cells.

Neeraj Pandey1, Robert E Schmidt, James E Galvin

  • 1Department of Neurology, Washington University School of Medicine, St. Louis, MO 63108, USA.

Experimental Neurology
|December 6, 2005
PubMed
Summary

New alpha-synuclein (AS) mutations, particularly E46KDeltaG, significantly enhance AS aggregation in cell models, aiding Parkinson's disease (PD) research. These findings offer insights into PD pathogenesis and Lewy body formation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Puppy Escape Narrative: Validation of an Openly Available Recall Task for MCI Detection.

medRxiv : the preprint server for health sciences·2026
Same author

The heat exposure, aging trajectories, and Alzheimer's disease (HEAT-AD) study protocol.

PloS one·2026
Same author

Defining and Measuring Cognitive Decline and Clinical Relevance.

Neurology and therapy·2026
Same author

Optimizing scalable approaches for early detection of cognitive impairment in primary care.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

Validating a Human Cell Model of Null Galactosylceramidase (GALC) Enzyme Activity That Recapitulates Krabbe Disease.

Journal of inherited metabolic disease·2026
Same author

MethylCog predicts six-year cognitive ability beyond blood-based ADRD biomarkers.

medRxiv : the preprint server for health sciences·2026

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Parkinson's disease (PD) involves alpha-synuclein (AS) aggregation into Lewy bodies.
  • Current in vitro models struggle to replicate AS aggregation effectively.

Purpose of the Study:

  • To generate and characterize novel AS mutations for improved in vitro modeling of PD.
  • To investigate the aggregation propensity of specific AS mutants.

Main Methods:

  • Generated AS mutations (A30P, A53T, E46K, E46KΔG) using PCR-based cloning.
  • Expressed wild-type and mutant AS in SH-SY5Y cells, assessing aggregation via microscopy and Western blot.
  • Analyzed inclusion morphology using electron microscopy.

Main Results:

Related Experiment Videos

  • The AS-E46KΔG mutant showed the highest aggregation rate (40%), followed by AS-E46K (18%).
  • Western blots confirmed high molecular weight AS aggregates.
  • Electron microscopy revealed two inclusion types resembling Lewy bodies and pale bodies.

Conclusions:

  • Mutations in the 4th KTKEGV repeat of AS, especially E46KΔG, significantly increase aggregation propensity.
  • These findings provide valuable models for studying PD pathogenesis and Lewy body formation in vitro.